PREDIAGNOSTIC PROSTATE-SPECIFIC ANTIGEN KINETICS ARE NOT ASSOCIATED WITH THE RISK OF PROGRESSION IN PROSTATE CANCER PATIENTS MANAGED WITH ACTIVE SURVEILLANCE

被引：0
|
作者：
Iremashvili, Viacheslav
Barney, Shane
Manoharan, Murugesan
Kava, Bruce
Parekh, Dipen J.
Punnen, Sanoj
机构：
来源：
JOURNAL OF UROLOGY | 2016年 / 195卷 / 04期
关键词：
D O I：
10.1016/j.juro.2016.02.2825
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD08-09
引用
收藏
页码：E231 / E232
页数：2
相关论文
共 50 条
  • [31] BIOMARKERS FOR PROSTATE CANCER DETECTION AND, PROGRESSION: BEYOND PROSTATE-SPECIFIC ANTIGEN
    Berney, Daniel M.
    [J]. DRUG NEWS & PERSPECTIVES, 2010, 23 (03) : 185 - 194
  • [32] Prostate-specific membrane antigen expression as a predictor of prostate cancer progression
    Perner, Sven
    Hofer, Matthias D.
    Kim, Robert
    Shah, Rajal B.
    Li, Haojie
    Moeller, Peter
    Hautmann, Richard E.
    Gschwend, Juergen E.
    Kuefer, Rainer
    Rubin, Mark A.
    [J]. HUMAN PATHOLOGY, 2007, 38 (05) : 696 - 701
  • [33] Prostate-specific antigen gene polymorphism and prostate cancer risk
    Sivonova, M.
    Matakova, T.
    Dobrota, D.
    Hatok, J.
    Kliment, J., Jr.
    Tomaskin, R.
    Kliment, J.
    [J]. EJC SUPPLEMENTS, 2008, 6 (03): : 53 - 54
  • [34] PROSTATE-SPECIFIC ANTIGEN RISES FASTER IN PATIENTS WITH MULTIPLE NEGATIVE BIOPSIES COMPARED TO PATIENTS FOLLOWED BY ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER
    Pujara, Akshat C.
    Stephenson, Andrew J.
    Miocinovic, Ranko
    Berglund, Ryan K.
    Jones, J. Stephen
    [J]. JOURNAL OF UROLOGY, 2010, 183 (04): : E831 - E831
  • [35] Prostate-specific antigen levels, prostate-specific antigen kinetics, and prostate cancer 496 prognosis: A tocsin calling for prospective studies
    Parekh, Dipen J.
    Ankerst, Donna P.
    Thompson, Ian M.
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (07) : 496 - 497
  • [36] Free prostate-specific antigen outperforms total prostate-specific antigen as a predictor of prostate volume in patients without prostate cancer
    Avci, Sinan
    Onen, Efe
    Caglayan, Volkan
    Kilic, Metin
    Sambel, Murat
    Oner, Sedat
    [J]. ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, 2020, 92 (01) : 1 - 6
  • [37] Is prostate-specific antigen progression a surrogate for objective clinical progression in early prostate cancer?
    Newling, D
    Carroll, K
    Morris, T
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 419S - 419S
  • [38] Prostate cancer screening with prostate-specific antigen in hemodialysis patients
    Horinaga, Minoru
    Kitamura, Koji
    Saito, Shiro
    Ukimura, Osamu
    Nakanoma, Takashi
    Okihara, Koji
    Kitagawa, Motonobu
    Nakanishi, Hiroyuki
    Miki, Tsuneharu
    [J]. UROLOGIA INTERNATIONALIS, 2007, 78 (04) : 334 - 337
  • [39] Assessment of Prostate-Specific Antigen (PSA) Kinetics in Prediction of Prostate Cancer on Prostate Biopsy
    Shinmei, S.
    Inoue, S.
    Ohkuchi, T.
    Yasukawa, A.
    [J]. UROLOGY, 2012, 80 (03) : S282 - S282
  • [40] Posttreatment Prostate-Specific Antigen Surveillance After Primary Treatment of Prostate Cancer
    Luh, Join Y.
    Harmon, Michael W.
    Eng, Tony Y.
    [J]. MAYO CLINIC PROCEEDINGS, 2013, 88 (03) : 307 - 308
12345